April 2026
1. SKOS C, Rogozarski J, Postula M, Eyileten C, et al
   Impact of direct oral anticoagulants on target lesion revascularization rates in patients with chronic coronary syndrome.
   J Thromb Haemost. 2026;24:1469-1481.
   

   >> Share

   
   March 2026
2. LI J, Gong Z, Wang S, Gu J, et al
   The Dual Role of P2RY12: Impact of Polymorphism and Expression on Ischemic Events and Bleeding in Patients with ST-Segment Elevation Myocardial Infarction Receiving Antithrombotic Therapy.
   J Thromb Haemost. 2026 Mar 26:S1538-7836(26)00206.
   

   >> Share

   
   
3. HELTEN C, Benkhoff M, Mourikis P, Metzen D, et al
   Acetylsalicylic acid improves outcome after acute myocardial infarction by reduction of thromboinflammation.
   J Thromb Haemost. 2026 Mar 4:S1538-7836(26)00119.
   

   >> Share

   
   January 2026
4. BAYARTAIKISHIGTAI D, Pei S, Chen Z, Luo F, et al
   Exploring the Prognostic Significance of Antiphospholipid Antibody in Acute Myocardial Infarction: Insights from Clinical Study and Mechanism.
   J Thromb Haemost. 2026 Jan 27:S1538-7836(26)00045.
   

   >> Share

   
   December 2025
5. BRAMBILLA M, Josefsson EC, Ramstrom S, Di Minno A, et al
   Biomarkers of in vivo platelet activation in coronary artery disease: a systematic review and meta-analysis: communication from the SSC of the ISTH.
   J Thromb Haemost. 2025;23:3989-4009.
   

   >> Share

   
   October 2025
6. COUGHLAN JJ, Durand R, Birrane J, Blackburne B, et al
   A history of the development of dual antiplatelet therapy for coronary artery disease.
   J Thromb Haemost. 2025;23:3336-3348.
   

   >> Share

   
   July 2025
7. WILCOX T, Smilowitz NR, Berger JS
   Association between preoperative platelet count and perioperative cardiovascular events after noncardiac surgery.
   J Thromb Haemost. 2025;23:2314-2321.
   

   >> Share

   
   June 2025
8. MROZ K, Paszek E, Polak M, Undas A, et al
   Prothrombotic fibrin clot phenotype as a risk factor for persistent left ventricular thrombus following acute myocardial infarction.
   J Thromb Haemost. 2025 Jun 10:S1538-7836(25)00361.
   

   >> Share

   
   
9. VAN EDOM CJ, Fiorelli F, Balthazar T, Monteagudo-Vela M, et al
   Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock.
   J Thromb Haemost. 2025;23:1810-1816.
   

   >> Share

   
   
10. MOUSSA MD, Abou-Arab O, Staessens S, Jungling M, et al
    Comparison of the effects of phosphorylcholin versus heparin-based surface coating on clinical and histologic outcomes during veno-arterial extracorporeal membrane oxygenation support: a propensity score weighted analysis.
    J Thromb Haemost. 2025;23:1879-1892.
    

    >> Share

    
    April 2025
11. ARIENS RA, McPherson HR, De Simone I, Huskens D, et al
    Length of ischaemia duration is associated with fibrin film coverage of acute myocardial infarction thrombi.
    J Thromb Haemost. 2025 Apr 24:S1538-7836(25)00266.
    

    >> Share

    
    January 2025
12. CHEN X, Liao X, Lu G, Ma Y, et al
    Aptamer BT200 is protective against myocardial ischemia-reperfusion injury in mice.
    J Thromb Haemost. 2025;23:222-234.
    

    >> Share

    
    December 2024
13. SUNDBOLL J, Veres K, Troelsen FS, Wurtz M, et al
    Myocardial infarction and short- or long-term risk of a subsequent cancer diagnosis: A Danish Nationwide Cohort Study.
    J Thromb Haemost. 2024 Dec 17:S1538-7836(24)00728.
    

    >> Share

    
    November 2024
14. POLZIN A, Benkhoff M, Thienel M, Barcik M, et al
    Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration.
    J Thromb Haemost. 2024 Nov 15:S1538-7836(24)00641.
    

    >> Share

    
    October 2024
15. VALERIANI E, Pannunzio A, Palumbo IM, Bartimoccia S, et al
    Risk of venous thromboembolism and arterial events in patients with hypoalbuminemia: a comprehensive meta-analysis of more than 2 million patients.
    J Thromb Haemost. 2024;22:2823-2833.
    

    >> Share

    
    August 2024
16. DOUKETIS JD, Yi Q, Bhatt DL, Muehlhofer E, et al
    Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial.
    J Thromb Haemost. 2024;22:2227-2233.
    

    >> Share

    
    May 2024
17. POCOCK SJ, Owen R, Gregson J, Mt-Isa S, et al
    Quantifying the benefit-risk trade-off for individual patients in a clinical trial: principles and antithrombotic case study.
    J Thromb Haemost. 2024;22:1399-1409.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share